IP Library Granted Patent US 12,636,240
Granted Patent B2
US 12,636,240 · App. 18/248,218 · Granted May 26, 2026

Antiperspirant composition

Inventors: Diego Takeshi Higa Araki (São Bernardo do Campo/ São Paulo, BR); Jose Elvecio Dos Santos Teixeira (Itapevi/ São Paulo, BR); Katia Nunes da Silva (Osasco— São Paulo, BR); Washington Romão Silva (Itapevi/ São Paulo, BR)
Assignee: Coty Inc.
A61K8/37A61K8/26A61K8/31A61K8/345A61K8/368A61Q15/00A61K2800/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,636,240
App. No.
18/248,218
Granted
May 26, 2026
Kind
B2
Abstract

Various aspects disclosed relate to an antiperspirant composition. The antiperspirant composition includes an isododecane component; an alkyl benzoate component; and a neopentyl glycol diheptanoate component.

Claims (25)

1 . An antiperspirant composition comprising:

an isododecane in a range of from about 10 wt % to about 30 wt % of the antiperspirant composition;

an alkyl benzoate in a range of from about 15 wt % to about 30 wt % of the antiperspirant composition;

a neopentyl glycol diheptanoate in a range of from about 1 wt % to about 10 wt % of the antiperspirant composition; and

PEG-30 dipolyhydroxystearate in a range of about 0.01 wt % to about 5 wt % of the antiperspirant composition, wherein the antiperspirant composition is free of cyclopentasiloxane.

2 . The antiperspirant composition of claim 1 , wherein the alkyl benzoate is a C12-15 alkyl benzoate.

3 . The antiperspirant composition of claim 1 , wherein the isododecane, alkyl benzoate, and neopentyl glycol diheptanoate together range from about 30 wt % to about 70 wt % of the antiperspirant composition.

4 . The antiperspirant composition of claim 1 , wherein the antiperspirant composition is in the form of a stick antiperspirant, a body spray, a clear gel, or an aerosol antiperspirant.

5 . The antiperspirant composition of claim 1 , further comprising a perfume.

6 . The antiperspirant composition of claim 1 , further comprising water.

7 . The antiperspirant composition of claim 1 , further comprising a deodorant active.

8 . The antiperspirant composition of claim 1 , further comprising an odor entrapping deodorant active.

9 . The antiperspirant composition of claim 1 , further comprising a buffering agent.

10 . The antiperspirant composition of claim 1 , further comprising a preservative.

11 . The antiperspirant composition of claim 1 , further comprising a propellant.

12 . The antiperspirant composition of claim 1 , further comprising an antiperspirant concentrate.

13 . The antiperspirant composition of claim 12 , wherein the concentrate comprises an alcohol.

14 . The antiperspirant composition of claim 1 , further comprising a suspending agent.

15 . The antiperspirant composition of claim 1 , further comprising an oil absorbent.

16 . A method of making the antiperspirant composition of claim 1 , the method comprising:

combining the isododecane; alkyl benzoate; neopentyl glycol diheptanoate; and the PEG-30 dipolyhydroxystearate.

17 . The antiperspirant composition of claim 1 , wherein the antiperspirant composition is in the form of an antiperspirant stick, an antiperspirant gel, or an antiperspirant spray.

18 . An assembly comprising:

a spray container; and

the antiperspirant composition of claim 1 .

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 22, 2024
From: COTY US LLC; COTY BRANDS MANAGEMENT INC.; CALVIN KLEIN COSMETIC CORPORATION; NOXELL CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069215/0826 →
SECURITY INTEREST Recorded Jun 4, 2024
From: COTY INC.; CALVIN KLEIN COSMETIC CORPORATION; COTY US LLC; COTY US HOLDINGS INC.; COTY BRANDS MANAGEMENT INC.; O P I PRODUCTS, INC.; NOXELL CORPORATION; THE WELLA CORPORATION
To: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT
Reel/Frame 067621/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2023
From: ARAKI, DIEGO TAKESHI HIGA; TEIXEIRA, JOSE ELVECIO DOS SANTOS; DA SILVA, KATIA NUNES; SILVA, WASHINGTON ROMÃO
To: COTY INC.
Reel/Frame 063249/0770 →
Continuity (2)
Provisional Application 63089603 · Oct 9, 2020
Related Publication 20230381076A1 · Nov 30, 2023
References Cited (28)
US 20030113283A1 · Mattai et al. · 2003 [cited by applicant]
US 20030161800A1 · Guenin et al. · 2003 [cited by applicant]
US 20040126337A1 · Singleton · 2004 [cited by examiner]
US 20140199252A1 · Yarlagadda et al. · 2014 [cited by applicant]
CN 103492029 · 2014 [cited by applicant]
CN 108136027 · 2018 [cited by applicant]
CN 110099663 · 2019 [cited by applicant]
CN 116367811 · 2023 [cited by applicant]
EP 2031235A2 · 2009 [cited by applicant]
EP 2949312A1 · 2015 [cited by applicant]
FR 2978034A1 · 2013 [cited by examiner]
WO WO0174306A2 · 2001 [cited by applicant]
WO WO0174325A2 · 2001 [cited by applicant]
WO WO02087516A3 · 2004 [cited by applicant]
WO WO2010068661A1 · 2010 [cited by applicant]
WO WO2011146491A2 · 2011 [cited by applicant]
WO WO2022076469A1 · 2022 [cited by applicant]
WO WO2022076469A8 · 2022 [cited by applicant]
English translation for FR-2978034-A1 (Aubrun) (Year: 2013). [cited by examiner]
“International Application Serial No. PCT/US2021/053643, International Search Report mailed Feb. 22, 2022”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2021/053643, Written Opinion mailed Feb. 22, 2022”, 5 pgs. [cited by applicant]
“Chinese Application Serial No. 202180068622.6, Decision of Rejection mailed Aug. 20, 2025”, w/o English Translation, 6 pgs. [cited by applicant]
“Chinese Application Serial No. 202180068622.6, Office Action mailed Jun. 9, 2025”, w/ English Translation, 14 pgs. [cited by applicant]
“Chinese Application Serial No. 202180068622.6, Response filed Aug. 5, 2025 to Office Action mailed Jun. 9, 2025”, w/ English Claims, 21 pgs. [cited by applicant]
“International Application Serial No. PCT US2021 053643, International Preliminary Report on Patentability mailed Apr. 20, 2023”, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 202180068622.6, Office Action mailed Oct. 17, 2024”, w Machine English Translation, 18 pgs. [cited by applicant]
“Chinese Application Serial No. 202180068622.6, Response filed Feb. 10, 2025 to Office Action mailed Oct. 17, 2024”, w current English claims, 22 pgs. [cited by applicant]
“European Application Serial No. 21801344.9, Communication Pursuant to Article 94(3) EPC mailed Feb. 27, 2025”, 3 pgs. [cited by applicant]